Navigation Links
PharmAthene Reports First Quarter 2008 Financial Results
Date:5/13/2008

87,121 shares issued and

outstanding; respectively, at

March 31, 2008 and December 31, 2007 2,209 2,209

Additional paid-in capital 127,278,108 126,490,647

Accumulated other comprehensive income 1,260,704 1,481,779

Accumulated deficit (92,420,179) (87,402,551)

Total stockholders' equity 36,120,842 40,572,084

Total liabilities and stockholders'

equity $62,223,155 $66,611,132

PharmAthene, Inc.

Consolidated Statements of Operations

(Unaudited)

Three months ended March 31,

2008 2007

(unaudited)

Contract and grant revenue $5,819,054 $2,961,759

Other revenue 21,151 7,000

5,840,205 2,968,759

Operating expenses:

Research and development 5,877,055 3,091,604

General and administrative 4,678,723 2,479,825

Depreciation and amortization 196,103 147,133

Total operating expenses 10,751,881 5,718,562

Loss from operations (4,911,676) (2,749,803)

Other income (expense):

Interest income 471,765 55,616

Interest expense (666,997) (241,781)

Change in market value of derivative

instruments 89,280 7,626

Total other expense (105,952)
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
2. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
3. PharmAthene Reports Year-End 2007 Financial Results
4. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
5. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
6. PharmAthene to Delay Release of Full Year 2007 Financial Results
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. PharmAthene to Present at the BIO CEO & Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... A new research platform uses a laser ... structures undergoing stress and heating, an approach ... for microelectronics and batteries., This new technique, ... how heating and the surface stress of ... have discussed the merits of surface-stress influence ...
(Date:8/28/2014)... SunTrust Robinson Humphrey (STRH) today announced the ... research team in biotechnology and oilfield services.  ... demonstrates our commitment to providing our valued institutional ... decision making," said Biff Woodruff , Head ... significant investments in differentiated content at a time ...
(Date:8/28/2014)... 28, 2014 A new market ... world is available from Strategic Consulting, Inc., the ... Industrial Microbiology Market Review, Fourth Edition: Global Review ... (IMMR—4) tracks and compares microbiology test volumes, market ... Europe and Asia, and forecasts future volumes and ...
(Date:8/27/2014)... Salt Lake City, Utah (PRWEB) August 27, 2014 ... new construction that will expand its current Salt Lake ... operations currently underway outside of Utah to ultimately create ... the next 20 years. , “Utah is home ... many of whom can be credited with Varian’s success ...
Breaking Biology Technology:New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3
... the promising field of cell therapy, in which cells are ... and tissue defects, researchers at Brigham and Women,s Hospital (BWH) ... challenges associated with the procedure: control of the cells and ... the journal Biomaterials on January 26, the team ...
... Feb. 2, 2011 Forensic DNA profiling has become ... in the aftermath of mass violence and disaster, but ... identify and analyze the major ethical and policy challenges ... (Logo: http://photos.prnewswire.com/prnh/20020422/CMULOGO) The National Institutes ...
... Elixir Bio-Tech Inc. (EBT), a New Mexico Algae Biotech ... winners of the FundingPost,s 7th annual "Pitching Across America™" ... Biomass Feedstock project in Luna County, NM to demonstrate ... and Patent Pending Technology for Open and Closed Algae ...
Cached Biology Technology:Engineered cells could usher in programmable cell therapies 2Engineered cells could usher in programmable cell therapies 3CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 2CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 3CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices 4Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors 2
(Date:8/28/2014)... MD FASEB MARC (Maximizing Access to Research ... for the Genetics Society of America,s 27th Annual ... October 3, 2014 in Pacific Grove, California. ... of students, post doctorates and scientists from underrepresented ... community and to encourage the participation of young ...
(Date:8/28/2014)... identified the developmental on-off switch for Streptomyces , ... two-thirds of the world,s naturally derived antibiotic medicines. ... it is possible to manipulate this switch to make ... appearing August 28 in Cell , found that ... and a larger protein called BldD ultimately controls whether ...
(Date:8/28/2014)... unique method for delivering compounds that could ... and AIDS may be possible, thanks to ... Sciences., A semi-soft vaginal suppository made from ... with the antiviral drug Tenofovir provides a ... the spread of sexually transmitted infections during ...
Breaking Biology News(10 mins):Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3
... LANSING, Mich. Michigan State University has been awarded ... the data coordinating center for the largest epidemiological study ... established in 2001 and now part of the university,s ... a repository for data from nearly 3,000 families as ...
... the winners of the 2009 SIB Best Graduate Paper and ... Basel Computational Biology Conference. **2009 SIB Young Bioinformatician ... Young Bioinformatician Award is SIB Member Lukas Burger, 29, who ... SIB in the Bioinformatics and Systems Biology Group led by ...
... the Louisiana Universities Marine Consortium, Louisiana State University, and the ... the coast of Louisiana and Texas in the Gulf of ... record. The dead zone is an area in the Gulf ... support most life in bottom and near-bottom waters. Scientists ...
Cached Biology News:MSU lands $2.1 million grant to take part in national autism study 2The SIB recognizes the next generation of bioinformaticians 2The SIB recognizes the next generation of bioinformaticians 3NOAA forecast predicts large 'dead zone' for Gulf of Mexico this summer 2NOAA forecast predicts large 'dead zone' for Gulf of Mexico this summer 3
... The PhosphatidylEthanolamine-Binding Protein (PEBP) does not ... protease inhibitors. PEBP is expressed ... testis, ovary, muscle, and stomach. ... in is exerting inhibitory activity against ...
...
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Request Info...
Biology Products: